Company Filing History:
Years Active: 2016-2020
Title: The Innovative Contributions of Betty Chan
Introduction
Betty Chan is a prominent inventor based in Harvard, MA, known for her significant contributions to the field of pharmaceutical sciences. With a focus on cancer treatment, she has developed innovative compounds that target specific mutations and mechanisms within cancer cells. Her work has led to the filing of two patents, showcasing her commitment to advancing medical research and therapeutic options.
Latest Patents
Betty Chan's latest patents include a crystalline form of (2S,3S,6S,7R,10R,E)-7,10-dihydroxy-3,7-dimethyl-12-oxo-2-((R,2E,4E)-6-(pyridin-2-yl)hepta-2,4-dien-2-yl)oxacyclododec-4-en-6-yl-4-methylpiperazine-1-carboxylate. This patent describes a novel solid-state form of pladienolide pyridine compounds, which may be useful in treating cancers that are responsive to agents targeting the spliceosome and its mutations. Additionally, her patent on pladienolide pyridine compounds provides pharmaceutical compositions and methods for using these compounds as therapeutic agents, further emphasizing their potential in cancer treatment.
Career Highlights
Betty Chan is currently employed at Eisai R&D Management Co., Ltd., where she continues to innovate and develop new therapeutic solutions. Her work is characterized by a strong emphasis on research and development, particularly in the area of oncology. Her contributions have not only advanced scientific knowledge but have also paved the way for new treatment options for patients suffering from cancer.
Collaborations
Throughout her career, Betty has collaborated with notable colleagues, including Gregg F. Keaney and John JianShi Wang. These collaborations have enhanced her research efforts and contributed to the successful development of her patented compounds.
Conclusion
Betty Chan's innovative work in the field of pharmaceutical sciences, particularly in cancer treatment, highlights her role as a leading inventor. Her patents reflect her dedication to improving therapeutic options for patients and advancing medical research.